Marjolein J. W. de Bruijn

Perinatal Activation of the Interleukin-33 Pathway Promotes Type 2 Immunity in the Developing Lung

Ismé M. de Kleer, Mirjam Kool, Marjolein J. W. de Bruijn et al. · Immunity · 2016 · 342 citations · Full text

Life Sciences, Developmental Biology, Immunology +16

Essential, dose-dependent role for the transcription factor <i>Gata3</i> in the development of IL-5 ⁺ and IL-13 ⁺ type 2 innate lymphoid cells

Roel G. J. Klein Wolterink, Nicolas Serafini, Menno van Nimwegen et al. · Proceedings of the National Academy of Sciences · 2013 · 226 citations · Full text

Life Sciences, Developmental Biology, Immunology +17

Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice

Laurens P. Kil, Marjolein J. W. de Bruijn, Menno van Nimwegen et al. · Blood · 2012 · 203 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Butyrate inhibits human mast cell activation via epigenetic regulation of FcεRI‐mediated signaling

Jelle Folkerts, Frank A. Redegeld, Gert Folkerts et al. · Allergy · 2020 · 173 citations · Full text

Life Sciences, Immunology, Nutritional Sciences +17

Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases

Esmee K. van der Ploeg, Korneliusz Golebski, Menno van Nimwegen et al. · Science Immunology · 2021 · 120 citations

Life Sciences, Immunology, Pathobiology +9